ProCE Banner Activity

Symptom Management in Bipolar Depression: Realistic Expectations and Strategies for Improvement

Podcast Episodes

Joseph F. Goldberg, MD, and Roger McIntyre, MD, FRCPC, discuss strategies and expectations for symptom management in bipolar depression, including the value of measurement-based care in optimizing patient outcomes.

Released: November 02, 2022

Expiration: November 01, 2023

No longer available for credit.

Share

Faculty

Joseph F. Goldberg

Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Roger S. McIntyre

Roger S. McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
University of Toronto, Canada
Toronto, Canada

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

AbbVie Inc.

Intra Cellular Therapies

Faculty Disclosure

Primary Author

Joseph F. Goldberg, MD

Clinical Professor of Psychiatry
Icahn School of Medicine at Mount Sinai
New York, New York

Joseph F. Goldberg, MD: consultant/advisor/speaker: BioXcel, Jazz, Lundbeck, Otsuka, Sage, Sunovion; fees for non-CME/CE services: AbbVie, Alkermes, Intra-Cellular Therapies, Sunovion.

Roger S. McIntyre, MD, FRCPC

Professor of Psychiatry and Pharmacology
University of Toronto, Canada
Toronto, Canada

Roger McIntyre, MD, FRCPC: researcher: CIHR/GACD/National Natural Science Foundation of China (NSFC), Milken Institute; consultant/speaker: Alkermes, AbbVie, Atai Life Sciences, Axsome, Bausch Health, Boehringer Ingelheim, Biogen, Eisai, IntraCellular, Janssen, Kris, Lundbeck, Mitsubishi Tanabe, Neumora Therapeutics, Neurocrine, NewBridge Pharmaceuticals, Novo Nordisk, Otsuka, Pfizer, Purdue, Sanofi, Sunovion, Takeda; executive role: Braxia Scientific Corporation.